Home / Companies / Theravance Biopharma U S Inc / Trends
Theravance Biopharma U S Inc H-1B trends
Quarterly LCA aggregate trend points for Theravance Biopharma U S Inc. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.
Summary
H-1B LCA filings for Theravance Biopharma U S Inc span 2017 Q2 to 2022 Q4, peaking at 6 filings in 2018 Q2.
The most recent reported period (2022 Q4) shows 1 filings.
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Period | LCA count | Role titles | SOC codes | Avg wage low | Avg prevailing | Certified | Certification rate |
|---|---|---|---|---|---|---|---|
| 2017 Q2 | 5 | 5 | 3 | $100,243 | $99,417 | 5 | 100.0% |
| 2018 Q2 | 6 | 4 | 3 | $117,366 | $109,555 | 6 | 100.0% |
| 2019 Q2 | 1 | 1 | 1 | $103,000 | $98,592 | 1 | 100.0% |
| 2020 Q1 | 4 | 3 | 3 | $174,004 | $161,584 | 4 | 100.0% |
| 2020 Q2 | 1 | 1 | 1 | $81,390 | $81,390 | 1 | 100.0% |
| 2020 Q4 | 1 | 1 | 1 | $200,000 | $174,845 | 1 | 100.0% |
| 2022 Q4 | 1 | 1 | 1 | $181,229 | $151,382 | 1 | 100.0% |
Frequently asked questions
- How have H-1B filings for Theravance Biopharma U S Inc changed over time?
- H-1B LCA filings for Theravance Biopharma U S Inc span 2017 Q2 to 2022 Q4, peaking at 6 filings in 2018 Q2. The most recent reported period (2022 Q4) shows 1 filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=theravance+biopharma+u+s+inc&metric=lca_countJSON